News

August 25, 2015 10:00 am
In his blog this week, IMF Chariman Dr. Brian Durie compares two opinions on the value of precision medicine as outlined in recent articles in Science and The New England Journal of Medicine. Although precision medicine is popular and ultimately...
August 25, 2015 10:00 am
Selinexor is an orally administered Selective Inhibitor of Nuclear Export, or SINE™, therapy for the treatment of multiple myeloma. Selinexor inhibits the transport of tumor suppressor proteins from the cell nucleus, where they detect cancerous DNA...
August 25, 2015 10:00 am
Emphasizing education, advocacy and support, the IMF Patient & Family Seminars empower patients and provide invaluable information to the myeloma community. Click here to watch the replay.
August 19, 2015 9:45 am
  The IMF Advocacy Team will meet with representatives from the Center for Medicare and Medicaid Services (CMS) next month to discuss current drug- and stem cell transplant-coverage policies. To prepare for the meeting, the IMF has created a short...

Pages